The tolerogenic molecule HLA-G

This publication has 20 references indexed in Scilit:

• ILT2/HLA‐G interaction impairs NK‐cell functions through the inhibition of the late but not the early events of the NK‐cell activating synapse
  The FASEB Journal, 2009
• HLA-G: from biology to clinical benefits
  Trends in Immunology, 2008
• CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance
  Blood, 2007
• Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells
  Stem Cells, 2007
• Human Neuroblastoma Cells Trigger an Immunosuppressive Program in Monocytes by Stimulating Soluble HLA-G Release
  Cancer Research, 2007
• Application of Human Leukocyte Antigen–G Expression in the Diagnosis of Human Cancer
  Human Immunology, 2007
• Trogocytosis‐based generation of suppressive NK cells
  The EMBO Journal, 2007
• HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia
  Blood, 2005
• HLA‐G up‐regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells
  The FASEB Journal, 2005
• HLA-G in Transplantation: A Relevant Molecule for Inhibition of Graft Rejection?
  American Journal of Transplantation, 2003